• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • CHMP recommends AstraZeneca’s Qtrilmet for type 2 diabetes pharmaceutical-technology
    September 25, 2019
    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the marketing authorisation of AstraZeneca’s Qtrilmet to treat type 2 diabetes in adults.
  • EMA CHMP recommends seven medicines for approval europeanpharmaceuticalreview
    September 25, 2019
    The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service